Acute heart failure syndromes -: Current state and framework for future research

被引:561
作者
Gheorghiade, M
Zannad, F
Sopko, G
Klein, L
Piña, IL
Konstam, MA
Massie, BM
Roland, E
Targum, S
Collins, SP
Filippatos, G
Tavazzi, L
机构
[1] Northwestern Univ, Feinberg Sch Med, Div Cardiol, Chicago, IL 60611 USA
[2] CHu Nancy, INSERM, Dommartin Les Toul, France
[3] NHLBI, Bethesda, MD 20892 USA
[4] Univ Hosp Cleveland, Cleveland, OH 44106 USA
[5] Tufts Univ New England Med Ctr, Boston, MA 02111 USA
[6] Vet Affairs Med Ctr, San Francisco, CA 94121 USA
[7] Agence Francaise Secur Sanitaire Prod Sante, Paris, France
[8] US FDA, Rockville, MD 20857 USA
[9] Univ Cincinnati, Cincinnati, OH USA
[10] Univ Athens Hosp Attikon, Athens, Greece
[11] IRCCS Policlin San Matteo, Pavia, Italy
关键词
heart failure; coronary disease; morbidity; mortality;
D O I
10.1161/CIRCULATIONAHA.105.590091
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:3958 / 3968
页数:11
相关论文
共 38 条
[11]   Impact of intravenous diuretics on the outcomes of patients hospitalized with Acute Decompensated Heart Failure:: Insights from the ADHERE® Registry [J].
Emerman, CL ;
De Marco, T ;
Costanzo, MR ;
Peacock, WF .
JOURNAL OF CARDIAC FAILURE, 2004, 10 (04) :S116-S117
[12]   Risk stratification after hospitalization for decompensated heart failure [J].
Felker, GM ;
Leimberger, JD ;
Califf, RM ;
Cuffe, MS ;
Massie, BM ;
Adams, KF ;
Gheorghiade, M ;
O'Connor, CM .
JOURNAL OF CARDIAC FAILURE, 2004, 10 (06) :460-466
[13]   Usefulness of anemia as a predictor of death and rehospitalization in patients with decompensated heart failure [J].
Felker, GM ;
Gattis, WA ;
Leimberger, JD ;
Adams, KF ;
Cuffe, MS ;
Gheorghiade, M ;
O'Connor, CM .
AMERICAN JOURNAL OF CARDIOLOGY, 2003, 92 (05) :625-628
[14]   Heart failure etiology and response to milrinone in decompensated heart failure - Results from the OPTIME-CHF study [J].
Felker, GM ;
Benza, RL ;
Chandler, AB ;
Leimberger, JD ;
Cuffe, MS ;
Califf, RM ;
Gheorghiade, M ;
O'Connor, CM .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (06) :997-1003
[15]   Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial [J].
Follath, F ;
Cleland, JGF ;
Just, H ;
Papp, JGY ;
Scholz, H ;
Peuhkurinen, K ;
Harjola, VP ;
Mitrovic, V ;
Abdalla, M ;
Sandell, EP ;
Lehtonen, L .
LANCET, 2002, 360 (9328) :196-202
[16]  
Fonarow G, 2005, J AM COLL CARDIOL, V45, p345A
[17]   Risk stratification for in-hospital mortality in acutely decompensated heart failure - Classification and regression tree analysis [J].
Fonarow, GC ;
Adams, KF ;
Abraham, WT ;
Yancy, CW ;
Boscardin, WJ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 293 (05) :572-580
[18]   ACUTE VASOCONSTRICTOR RESPONSE TO INTRAVENOUS FUROSEMIDE IN PATIENTS WITH CHRONIC CONGESTIVE HEART-FAILURE - ACTIVATION OF THE NEUROHUMORAL AXIS [J].
FRANCIS, GS ;
SIEGEL, RM ;
GOLDSMITH, SR ;
OLIVARI, MT ;
LEVINE, TB ;
COHN, JN .
ANNALS OF INTERNAL MEDICINE, 1985, 103 (01) :1-6
[19]   Effects of tolvaptan, a vasopressin antagonist, in patients hospitalized with worsening heart failure - A randomized controlled trial [J].
Gheorghiade, M ;
Gattis, WA ;
O'Connor, CM ;
Adams, KF ;
Elkayam, U ;
Barbagelata, A ;
Ghali, JK ;
Benza, RL ;
McGrew, FA ;
Klapholz, M ;
Ouyang, J ;
Orlandi, C .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 291 (16) :1963-1971
[20]   BG9719 (CVT-124), an A1 adenosine receptor antagonist, protects against the decline in renal function observed with diuretic therapy [J].
Gottlieb, SS ;
Brater, DC ;
Thomas, I ;
Havranek, E ;
Bourge, R ;
Goldman, S ;
Dyer, F ;
Gomez, M ;
Bennett, D ;
Ticho, B ;
Beckman, E ;
Abraham, WT .
CIRCULATION, 2002, 105 (11) :1348-1353